Wisconsin · Nonprofit
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC (Wisconsin) receives grants from 2 organizations whose IRS filings report $96,500 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($66,500). 2 of them have funded it in more than one year.
- Revenue FY2024
- $2.4M
- Funders on record
- 2
- Grants received
- $97k
- Net assets
- $1.5M
What Coalition of State Rheumatology Organizations Inc does
Mission
The organization is comprised of state and regional professional rheumatology societies, whose mission is to advocate for excellence in the field of rheumatology, ensuring access to the highest quality care for the management of rheumatalogic and musculoskeletal diseases.
As stated on its FY2024 Form 990.
Programs
Conferences and seminars promoting understanding of and participation in advocacy by practicing rheumatologists to encourage legislation and policy that positively benefits their patients and specialty; conferences and webinars supporting the transition of rheumatology fellows from academic study to careers in rheumatology, as well as continued professional development.
$1,018,544 spentof which $40,500 as grants57% of program spendingSupporting state society members in their advocacy efforts by tracking legislation in all 50 states, providing grants to underwrite costs of in-person advocacy days at state capitals, encouraging the formation of new state societies, and comprehensive communications to keep members informed of activities and opportunities for engagement.
$784,056 spent$15,500 earned by the program43% of program spending
The 2 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $1,802,600.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $1.9M to $2.5M (+30%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
97% of COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2022 → 2023: the base broadened from 1 funder to 2 funders, grant income rose $10k → $37k.
From the IRS filings of COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC leans on a few funders — its largest provides 69% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC.
Largest funder’s share by year: 2022 100% · 2023 73% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC draws 100% of its grant income from funders outside Wisconsin, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC is better cushioned than half of the 8,121 health nonprofits its size.
this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024
Organizations like COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Wisconsin
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
78% of spending goes to programs.
Governance
Public support
54%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC?
- COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC (Wisconsin) receives grants from 2 organizations whose IRS filings report $96,500 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($66,500). 2 of them have funded it in more than one year.
- How many funders does COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC have?
- IRS filings report 2 organizations giving $96,500 in grants to COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC, 2 of which have funded it in more than one year.
- Who is the largest funder of COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC?
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is the largest funder on record, with $66,500 in grants. The full list of funders is on this page.
- How can an organization like COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Wisconsin. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing